Purchase Order 36C26224P0018
Award Date 10/1/23
Potential Completion Date 3/31/24
Potential Value $1.1M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, is for an extended warranty on the FILMARRAY SYSTEM, a molecular diagnostic testing platform used for syndromic infectious disease identification. The $429,029.10 firm fixed-price delivery order was placed by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) VISN 12. Biofire Diagnostics is an experienced federal contractor, holding several indefinite delivery contracts and...
- This is a $151,055.55 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The award is for the Biofire Touch System and molecular diagnostic multiplex kits, which are used for syndromic infectious disease testing. This purchase is not associated with any set-aside designations. The award is part of Biofire's existing General Services Administration (GSA)...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 (VISN 22) to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The contract, valued at $645,472.66, is for the delivery of the "TISSUE TRACKER" product and has an ultimate completion date of September 30, 2024. The contract was awarded on April 1, 2024 and does not have a set-aside designation. Biofire...
- This is a $34,704 firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company specializing in advanced molecular diagnostic testing solutions. The contract is funded through the VA's Veterans Integrated Service Network 23 (VISN 23) and will support the delivery of BIOFIRE products and services through September 30, 2023. Biofire Diagnostics is an experienced federal contractor, holding...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization that specializes in syndromic infectious disease testing. The $125,500.00 firm-fixed-price purchase order does not have a set-aside designation. Biofire Diagnostics LLC has received numerous federal contracts as a prime contractor to provide a variety of goods and services related to infectious disease...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $121,440.00 firm fixed-price contract is for the provision of BIOFIRE diagnostic products and services, issued under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents,...
- This $172,948.90 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the delivery of BIOFIRE REAGENT. The contract has a completion date of May 15, 2021 and was awarded on July 14, 2020 with no set-aside designation used. Biofire Diagnostics is the leader in syndromic infectious disease testing and has received numerous federal contracts to provide...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 22 to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The $514,702.52 firm-fixed-price order is for the delivery of infectious disease testing products and services from Biofire Diagnostics' General Services Administration (GSA) Federal Supply Schedule contract. The order provides the VA VISN 22 with Biofire's molecular...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The one-year, $808,537.12 delivery order contract is for Firm Fixed Price infectious disease testing products and services, including molecular diagnostic testing, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The contract is for $265,350.00 and was awarded on May 15, 2018 with a completion date of July 9, 2018. The work is not set-aside and is being performed under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. Biofire...
This is a $1,126,210.90 firm fixed price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The contract is for Biofire's Tissue Tracker software, which supports syndromic infectious disease testing. Biofire Diagnostics is an established federal contractor, holding GSA Federal Supply Schedule contracts and other indefinite delivery vehicles with VHA, the Defense Health Agency, and Indian Health Service to provide a range of infectious disease testing products and services. This award does not utilize any set-aside designations. The contract has a performance period through March 31, 2024.
Generated 10/1/24, 12:36 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($3k) | 5/14/24 | |
| P00001 | Supplemental Agreement for work within scope | $474.4k | 2/3/24 | |
| Not listed | Not listed | $654.7k | 10/1/23 |